Changes in peripheral lymphocyte subsets in patients after partial microwave ablation of the spleen for secondary splenomegaly and hypersplenism: A preliminary study

References

• Yang Z, Qiu F. Pericardial devascularization with splenectomy for the treatment of portal hypertension. Zhonghua Wai Ke Za Zhi 2000; 38: 645–648
   PubMedGoogle Scholar
• Sugawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Takayama T, Makuuchi M. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg 2000; 190: 446–450
   PubMedGoogle Scholar
• Tomikawa M, Hashizume M, Akahoshi T, Shimabukuro R, Gotoh N, Ohta M, Sugimachi K. Effects of splenectomy on liver volume and prognosis of cirrhosis in patients with esophageal varices. J Gastroenterol Hepatol 2002; 17: 77–80
   PubMedGoogle Scholar
• Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: Postsplenectomy sepsis revisited. Pediatr Dev Pathol 2001; 4: 105–121
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Holmes EM, Toolis F, Wayne B, Chalmers J, Jones IG, Campbell H. Evaluation of severe infection and survival after splenectomy. Am J Med 2006; 119: 276e1–7
   Google Scholar
• Trobs RB, Bennek J. Partial splenectomy, transposition of the spleen to the abdominal wall or splenohepatoplasty in portal hypertensive rats. Effects on portal venous pressure and homeostasis–microscopical appearance of the transposed spleen. Eur J Pediatr Surg 1998; 8: 155–162
   PubMedGoogle Scholar
• Jiang HC, Sun B, Qiao HQ, Xu J, Piao DX, Yin H. Clinical application of serial operations with preserving spleen. World J Gastroenterol 2001; 7: 876–879
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen J, Kaiser GM, Mapudengo O, Zhang J, Exton MS, Song E. The value of partial splenic autotransplantation in patients with portal hypertension: A prospective randomized study. Arch Surg 2002; 137: 89–93
   PubMedGoogle Scholar
• Obatake M, Muraji T, Kanegawa K, Satoh S, Nishijima E, Tsugawa C. A new volumetric evaluation of partial splenic embolization for hypersplenism in biliary astresia. J Pediatr Surg 2001; 36: 1615–1616
   PubMedGoogle Scholar
• Liu FQ, Chu GW, Tong JM, Zhang XJ, Qin DJ, Liu YL, Chen GH. Studies of treatment of hypersplenism with injection of absolute alcohol into spleens. Shijie Huaren Xiaohua Za Zhi 2000; 8: 1381–1384
   Google Scholar
• Shina S, Aoyama H, Shiratori Y, Mutoh H, Kurita M, Ota S, Terano A, Sugimoto T. Ultrasound-guided percutaneous injection of ethanolamine oleate for hypersplenism. An experimental study in dogs. Invest Radiol 1990; 25: 651–657
   PubMedGoogle Scholar
• Liu QD, Ma KS, He ZP, Ding J, Huang XQ, Dong JH. Experimental study on the feasibility and safety of radiofrequency ablation for secondary splenomagely and hyper-splenism. World J Gastroenterol 2003; 9: 813–817
   PubMed Web of Science ®Google Scholar
• Tabuse K, Katsumi M, Kobayashi Y, Noguchi H, Egawa H, Aoyama O, Kim H, Nagai Y, Yamaue H, Mori K, Azoma Y, Tsuji T. Microwave surgery: Hepatectomy using a microwave tissue coagulator. World J Surg 1985; 9: 136–143
   PubMed Web of Science ®Google Scholar
• Hornback NB, Shupe R, Shidnia H, Joe BT, Sayoc E, George R, Marshal C. Radiation and microwave therapy in the treatment of advanced cancer. Radiology 1979; 130: 459–464
   PubMed Web of Science ®Google Scholar
• Ohmoto K, Miyake I, Tsuduki M, Shibata N, Takesue M, Kunieda T, Ohno S, Kuboki M, Yamamoto S. Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 2894–2900
   PubMedGoogle Scholar
• Mikami Y, Shimizu M, Manabe T. Tumorous necrotic nodule in the liver: Unexpected effect of the microwave tissue coagulator. J Clin Pathol 1997; 50: 703–705
   PubMedGoogle Scholar
• Seki T, Kubota Y, Wakabayashi M, Kunieda K, Nakatani S, Shiro T, Inoue K. Percutaneous transhepatic microwave coagulation therapy for hepatocellular carcinoma proliferating in the bile duct. Dig Dis Sci 1994; 39: 663–666
   PubMedGoogle Scholar
• Sato M, Watanabe Y, Kashu Y, Nakata T, Hamada Y, Kawachi K. Sequential percutaneous microwave coagulation therapy for liver cancer. Am J Surg 1998; 175: 322–324
   PubMedGoogle Scholar
• Matsukawa T, Yamashita Y, Arakawa A, Nishiharu T, Urata J, Murakami R, Takahashi M, Yoshimatsu S. Percutaneous microwave coagulation therapy in liver tumors. A 3-year experience. Acta Radiol 1997; 38: 410–415
   PubMed Web of Science ®Google Scholar
• Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000; 89: 276–284
   PubMed Web of Science ®Google Scholar
• Murakami T, Shibata T, Ishida T, Niinobu T, Satoh T, Takamura M, Shibata N, Takami M, Nakamura H. Percutaneous microwave hepatic tumor coagulation with segmental hepatic blood flow occlusion in seven patients. AJR Am J Roentgenol 1999; 172: 637–640
   PubMedGoogle Scholar
• Liang P, Dong BW, Yu XL, Yu DJ, Wang Y, Feng L, Xiao QJ. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005; 235: 299–307
   PubMed Web of Science ®Google Scholar
• Dong BW, Zhang J, Liang P, Yu XL, Su L, Yu DJ, Ji XL, Yu G. Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma. Int J Hyperthermia 2003; 19: 119–133
   PubMed Web of Science ®Google Scholar
• Zhang J, Dong BW, Liang P, Yu XL, Su L, Yu DJ, Ji XL, Yu G. Significance of changes in local immunity in patients with hepatocellular after percutaneous microwave coagulation therapy. Chin Med J 2002; 115: 1367–1371
   PubMed Web of Science ®Google Scholar
• Nakayama J, Kokuba H, Kobayahshi J, Yoshida Y, Hori Y. Experimental approaches for the treatment of murine B16 melanomas of various sizes. II: Injection of ethanol with combinations of beta-interferon and microwaval hyperthermia for B16 melanomas with a size of greater than 10 mm in diameter. J Dermatol Sci 1997; 15: 82–88
   PubMed Web of Science ®Google Scholar
• Szmigielski S, Sobczynski J, Sokolska G, Stawarz B, Zielinski H, Petrovich Z. Effects of local prostatic hyperthermia on human NK and T cell function. Int J Hyperthermia 1991; 7: 869–880
   PubMed Web of Science ®Google Scholar
• Hong X, Baowei D, Xingshi L. Changes of T-lymphocyte subsets in patients with liver cancer treated by ultrasound-guide percutaneous microwave coagulation. Chin J Phys Ther 2000; 1: 15–17
   Google Scholar
• Siemion IZ, Kluczyk A. Tuftsin. On the 30-year anniversary of Victor Najjar's discovery. Peptides 1999; 20: 645–674
   PubMed Web of Science ®Google Scholar
• Vliet E, Melis M, Ewijk W. Marginal zone Macrophages in the mouse spleen identified by a monoclonal antibody. Anatomical correlation with a B cell subpopulation. J Histochem Cytochem 1985; 33: 40–44
   PubMedGoogle Scholar
• Fan WC, King KL, Loong CC, Wu CW. Hepatocellular carcinoma after renal transplantation: The long-term impact of cirrhosis on chronic B virus infection. Transplant Proc 2006; 38: 2080–2083
   PubMedGoogle Scholar
• Joseph FP, Gregory LA, Leigh AF, Yvan JFH, Beth PB. The contribution of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529–538
   PubMedGoogle Scholar
• Meyer JL. Hyperthermia as an anticancer modality: A historical perspective. Front Radiat Ther Oncol 1984; 18: 1–22
   PubMedGoogle Scholar
• Santini R, Hosni M, Douss T, Deschaux P, Pacheco H. Increasing antigenecity of B16 melanoma cell fraction with microwave hyperthermia. J Microw Power Electromagn Energy 1986; 21: 41–44
   PubMed Web of Science ®Google Scholar
• Wu Y, Jiang NY, Cheng QS, Li XF, Wang XP, Liu K. Assessment of immune cells from patients with lung cancer before and after radiofrequency ablation. J Fourth Mil Med Univ 2004; 25: 671–672
   Google Scholar
• Troisi R, Hoste E, Langenhove PV, Decruyenaere J, Voet D, Hesse UJ, Cuomo O, Hemptinne BD. Modulation of liver graft hemodynamics by partial ablation of the splenic circuit: A way to increase hepatic artery flow?. Transplant Proc 2001; 33: 1445–1446
   PubMedGoogle Scholar
• Kim S, Lizuka K, Aguila HL, Weissman IL, Yokoyama WM. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci USA 2000; 97: 2731–2736
   PubMed Web of Science ®Google Scholar
• Zhu KS, Shan H, Li ZR, Shen XY, Meng XC, Guan SH, Jiang ZB, Huang MS. Long-term efficacy of partial splenic embolization for hypersplenism in cirrhosis. Chin J Radiol 2004; 38: 732–736
   Google Scholar
• Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, Ruiz J, Zozaya JM, Quiroga J, Prieto J. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 1993; 18: 309–314
   PubMed Web of Science ®Google Scholar